Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.
Article in Cancer Discovery (June 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Cancer Discovery (June 2024)
Article in Nature Communications (May 2024)
Article in Journal of Neuroinflammation (March 2024)